TLSC blir medlem i Abelia

TLSC blir medlem i Abelia

For å styrke våre muligheter til å påvirke rammebetingelsene for life science bedriftene har The Life Science Cluster meldt seg inn i Abelia og NHO. Abelia er NHOs forening for kunnskaps- og teknologibedrifter, og har over 1900 medlemmer med omlag 46.000 årsverk....
Vaccibody raises 24 million Euro!

Vaccibody raises 24 million Euro!

On the 15th of December Vaccibody – vaccine startup and TLSC-member – announced the great news that they have successfully completed a Private Placement funding round, raising NOK 220 million (€ 24 million) ! The Private Placement was significantly oversubscribed by...
THE SWISS BIOTECH INDUSTRY

THE SWISS BIOTECH INDUSTRY

Switzerland has a very strong biotech industry. 220 R&D companies, 60 supplier companies, and many excellent research communities make up a thriving high-tech cluster. The sector has a total turnover of over 43,6 Billion NOK (4,8 Billion EUR). Now there is a...
THE POTENTIAL IS HUGE!

THE POTENTIAL IS HUGE!

The momentum behind The Life Science Cluster is building. So far, 40 companies and organizations have signed up as members, and more are joining by the week. Our first three member-driven workgroups are busy generating activities and planning projects. And the board...